Porcine Corneal Tissue and Xenozoonotic Risks: A Review of the Current Evidence
Xenotransplantation · 2025-11 · 32 (6)
DOI: 10.1111/xen.70068 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Xenotransplantation, online erschienen am 07.11.2025. Verfasst von Rodrigo Moreira und 13 weiteren Autor:innen. Beteiligte Einrichtung: Vision Institute (IPEPO), São Paulo, Brazil. Hauptthemen laut MEDLINE: Transplantation, Heterologous, Corneal Transplantation, Cornea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: by FAPESP.
Abstract (Originalsprache)
Corneal opacities affect millions worldwide, with corneal transplantation as the primary treatment. However, donor shortages remain a challenge, leaving thousands waiting for transplants. Xenotransplantation using porcine corneas has emerged as a promising alternative due to anatomical and physiological similarities with human corneas. Advances in CRISPR/Cas technology enable genetic modifications to address immune rejection and zoonotic risks. A key concern is xenozoonosis, the transmission of infectious agents from pigs to humans. Pathogens such as porcine endogenous retroviruses (PERVs), porcine cytomegalovirus (PCMV), and bacteria pose potential risks. While PERVs can infect human cells in vitro, no transmission has been documented in vivo. Regulatory bodies, including the WHO and IXA, have established guidelines for monitoring and clinical trials. The first human corneal xenotransplantation trials in South Korea and China are underway. Enhanced biosecurity measures in tissue banks have reduced microbial contamination, improving safety. Corneal xenotransplantation presents lower risks compared to solid organ xenotransplants. With ongoing research, stringent regulations, and improved pathogen‐free animal models, this technique could become a viable clinical option. Future human trials will provide crucial insights into its long‐term safety and effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vision Institute (IPEPO), São Paulo, Brazil.
- Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
- Federal University of Viçosa (UFV), Viçosa, Brazil.
- University of São Paulo (USP), São Paulo, Brazil.
ORCID-Profile: Rodrigo Moreira, Silvano Raia
Förderung
- by FAPESP
Zitieren
APA
Moreira, R., Nascimento, H., Martins, T. M. D. M., Barbieri, G., Pires, P., Carvalho, L. N., Rosa, L. R., Almeida, A., Pessuti, C. L., Ferrer, H., Gomes, J. Á. P., Goulart, E., Raia, S., & Belfort, R. (2025). Porcine Corneal Tissue and Xenozoonotic Risks: A Review of the Current Evidence. Xenotransplantation, 32(6). https://doi.org/10.1111/xen.70068
Vancouver
Moreira R, Nascimento H, Martins TMDM, Barbieri G, Pires P, Carvalho LN, et al. Porcine Corneal Tissue and Xenozoonotic Risks: A Review of the Current Evidence. Xenotransplantation. 2025;32(6). doi:10.1111/xen.70068
BibTeX
@article{Moreira2025,
author = {Moreira, Rodrigo and Nascimento, Heloisa and Martins, Thaís Maria da Mata and Barbieri, Gabriel and Pires, Pedro and Carvalho, Lucimeire N and Rosa, Larissa R and Almeida, Augusto and Pessuti, Carmen Luz and Ferrer, Henrique and Gomes, José Álvaro Pereira and Goulart, Ernesto and Raia, Silvano and Belfort, Rubens},
title = {Porcine Corneal Tissue and Xenozoonotic Risks: A Review of the Current Evidence},
journal = {Xenotransplantation},
year = {2025},
volume = {32},
number = {6},
doi = {10.1111/xen.70068}
}
EUVIMED